Accessibility Menu
 
International Biotechnology Trust Plc logo

International Biotechnology Trust Plc

(LSE) IBT

Current Price$990.00
Market Cap$31.06B
Since IPO (1994)+1,434%
5 Year+42%
1 Year+69%
1 Month+1%

International Biotechnology Trust Plc Financials at a Glance

Market Cap

$31.06B

Revenue (TTM)

$61.57M

Net Income (TTM)

$37.71M

EPS (TTM)

$-4.92

P/E Ratio

-198.37

Dividend

$31.81

Beta (Volatility)

0.06 (Low)

Price

$990.00

Volume

28,253

Open

$968.00

Previous Close

$990.00

Daily Range

$968.00 - $990.00

52-Week Range

$548.00 - $1010.00

IBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Biotechnology Trust Plc

Industry

Capital Markets

Employees

0

Headquarters

London, WC2B 6ST, GB

IBT Financials

Key Financial Metrics (TTM)

Gross Margin

20%

Operating Margin

-0%

Net Income Margin

-6%

Return on Equity

-44%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-0.50%

Dividend Yield

3.26%

Payout Ratio

-9.57%

Stock Overview

Market Cap

$31.06B

Shares Outstanding

31.83M

Volume

28.25K

Avg. Volume

52.37K

Financials (TTM)

Gross Profit

$14.38M

Operating Income

$21.00K

EBITDA

$21.00K

Operating Cash Flow

$28.63M

Capital Expenditure

$28.63M

Free Cash Flow

$0.00

Cash & ST Invst.

$14.98M

Total Debt

$29.61M

International Biotechnology Trust Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$5.99M

+172.4%

Gross Profit

$8.98M

-8.5%

Gross Margin

-1.50%

N/A

Market Cap

$31.06B

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

$8.20M

+19.1%

EBITDA

$9.45M

-2838.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.63M

+55.0%

Accounts Receivable

$66.00K

-97.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$29.61M

-8.8%

Return on Assets

-0.41%

N/A

Return on Invested Capital

-0.01%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$31.30M

+446.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BSV.LBritish Smaller Companies VCT plc
$74.50+0.00%
BIOG.LThe Biotech Growth Trust PLC
$1350.00+1.96%
ARR.LAurora Investment Trust plc
$239.00-0.42%
STS.LSTS Global Income & Growth Trust PLC
$223.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$16.42+0.05%
NOKNokia
$13.80+0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.88+0.01%
ODYSOdysight.ai
$5.56+0.25%

Questions About IBT

What is the current price of International Biotechnology Trust Plc?

International Biotechnology Trust Plc is trading at GBX 990.00 per share.

What is the 52-week range for International Biotechnology Trust Plc?

Over the past 52 weeks, International Biotechnology Trust Plc has traded between GBX 548.00 and GBX 1,010.00.

How much debt does International Biotechnology Trust Plc have?

As of the most recent reporting period, International Biotechnology Trust Plc reported total debt of $29.61M.

How much cash does International Biotechnology Trust Plc have on hand?

International Biotechnology Trust Plc reported $14.98M in cash and cash equivalents in its most recent financial results.

What is International Biotechnology Trust Plc’s dividend yield?

International Biotechnology Trust Plc currently has a dividend yield of 3.26%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.